Development of Dengue virus type 2 replicons capable of prolonged expression in host cells

BACKGROUND: As part of a program to develop a Dengue virus vaccine which avoids the deleterious effects of antibody dependent enhancement (ADE) of infection mediated by antibodies to Dengue virus structural proteins, we have begun to investigate the possibility of designing Dengue vaccines based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Xiaowu, Zhang, Mingjie, Dayton, Andrew I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC56997/
https://www.ncbi.nlm.nih.gov/pubmed/11580862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC56997/
https://www.ncbi.nlm.nih.gov/pubmed/11580862

Ejemplares similares